| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |